Some studies have indicated that the higher the MCL risk group, the higher the percentage of patients with > 50% TP53 expression, and the expression of TP53 is related to the outcome of MCL independent of the MIPI and Ki-67 level [14, 45]. This evidence concerns the gene MKI67 and mantle cell lymphoma.